|
Presidential Primaries: Who
Should Get Your ePrescribing Vote?
by Tony Schueth,
Editor-in-Chief
As stakeholders
in ePrescribing, you may be wondering which presidential candidates
would be the friendliest toward ePrescribing, especially important
given the impact Washington has had on health information technology
(HIT), in general.
The most vocal
candidate was Gov. Tommy Thompson, R-WI. The former secretary of
Health and Human Services dropped out of the race in August after
finishing 6th in an Iowa straw poll.
Among the
remaining presidential aspirants, Sen. Hilary Clinton, D-NY, has
advocated electronic health records on the campaign circuit and
supported ePrescribing in testimony in Washington. One of the
sponsors of the Wired for
Healthcare Quality Act of 2007, Sen.
Clinton's health care plan includes an "investment" of $3 billion a
year in HIT grants.
Her closest
rival, Sen. Barak Obama, D-IL, doesn’t have Sen. Clinton’s record
and, to our knowledge, hasn’t talked about ePrescribing, but he has
mentioned HIT on the campaign trail and proposed $10 billion per
year over the next
five years to move the US health care system to broad adoption of
standards-based electronic health information systems, including
electronic health records.
Furthermore, he has been endorsed by former presidential candidate
Sen. John Kerry, D-MA, who would presumably have his ear and Sen.
Ted Kennedy, D-MA. Both Sen. Kerry and Sen Kennedy are strong
advocates of ePrescribing, with Kerry having sponsored a bill to
mandate the practice.
On the
Republican side, the front-runner of the still-crowded field may be
former Massachusetts Governor Mitt Romney. With Massachusetts being
an ePrescribing bellwether state, Romney witnessed firsthand the
value of ePrescribing during his tenure. Presumably, hometown
ePrescribing advocates would have his ear.
The Republican
candidate who worries us most is former New York City Mayor Rudy
Giuliani. Previously a prosecutor, we are
concerned that he may be more sympathetic to the Drug Enforcement
Agency’s (DEA) reluctance to permit electronic transmission of
prescriptions for controlled substances. As we have documented in
past issues, this is perhaps the largest of the remaining barriers
to ePrescribing because of the challenges associated with dual
methods of entering prescriptions.
With a primary
today in our home state of Florida, we had the chance to ask the
Giuliani camp about this subject. While this issue is too small for
him to have stated a position, staffers dodged the question and
referred to Newt Gingrich, the former Republican Speaker of the
House of Representatives who now runs the Center for Healthcare
Transformation and is a strong advocate of ePrescribing. Even though
Gingrich hasn’t yet endorsed a candidate, he would naturally have
influence with a Republican, should one win the White House.
Furthermore, HIT, in general, could be labeled a “legacy” issue for
the Bush administration, despite bipartisan support for the subject.
To the degree that a Republican would have a good relationship with
the next administration, the future may be bright.
In our view, it
really doesn’t matter who you vote for. ePrescribing has the support
of both parties and better days are ahead. So, it shouldn’t be a
consideration when selecting a candidate.
With Washington
such a hotbed for eRx, it’s worthy to note that experts believe
ePrescribing will be among its top priorities in 2008, according to
an article in the January issue of Healthcare IT News. One
topic will certainly be ePrescribing mandates, which
were removed from the Medicare bill
in December.. Though supported by the Bush administration, liberal
Democrats and conservative Republicans, it has been stalled in
committee, according to the January 14 issue of iHealthBeat.
Its concern has less to do with ePrescribing than other elements of
the bill.
The energy
behind mandates has come from the Pharmaceutical Care Management
Association (PCMA), which has lobbied, created an advertisement and
assembled a coalition of various stakeholders, including
physicians. The Blue Cross Blue Shield Association recently called
for mandates, as well.
In reaction to
the “m-word,” there seems to be two schools of thought. In one,
incentives are levers for changing behavior, and just getting
physicians to use eRx doesn’t provide the value of having them use
it in a certain way. With others, the thinking is, “If the
government is going to pay, why should we?” We must remind payers
that there are pros and cons to both carrots and sticks. If you need
expert help thinking through the options, let us know.
On related
subjects, did you notice that … three Democratic lawmakers have
formed a congressional task force to push stalled HIT
legislation, according to iHealthBeat.
Reps. Lois Capps, D-CA, Allyson
Schwartz, D-PA and Jason Altmire, D-PA will lead it. … Nineteen
senators have sent a letter to US Attorney General Michael
Mukasey urging him to expedite efforts within the DEA to permit
electronic prescribing for controlled substances, Government
Health IT reported in December. The DEA said that it would
respond to a request by Sen. Sheldon Whitehouse, D-RI, for a
timeline within 60 days, so look for a Valentine’s card from Joseph
Rannazzisi, head of the DEA's Office of Diversion Control. …
RxHub announced it has 200 million lives in its master patient
index and its volume has increased by 38% over 2006. … Walgreens
has set an objective of receiving 1.8 million eRxs in 2008 and will
partner with some physician groups. … SureScripts CEO Kevin
Hutchinson is leaving the company at the end of January. …
Allscripts, NextGen and DrFirst have achieved
SureScripts' GoldRx certification. Allscripts also claimed it had
the most ePrescriptions go through SureScripts in 2007. …
DrFirst has an iPhone version of its product.
We also
understand there have been 75 responses to the Notice of Proposed
Rule-Making (NPRM) on ePrescribing Standards. Unless something has
changed, those will be posted for public view at some point in the
near future. |